Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
30.91
-2.67 (-7.95%)
At close: May 1, 2026, 4:00 PM EDT
31.11
+0.20 (0.65%)
After-hours: May 1, 2026, 7:48 PM EDT
Capricor Therapeutics Employees
Capricor Therapeutics had 231 employees as of December 31, 2025. The number of employees increased by 71 or 44.38% compared to the previous year.
Employees
231
Change (1Y)
71
Growth (1Y)
44.38%
Revenue / Employee
n/a
Profits / Employee
-$454,736
Market Cap
1.79B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 231 | 71 | 44.38% | 231 | 0 |
| Dec 31, 2024 | 160 | 58 | 56.86% | 160 | 0 |
| Dec 31, 2023 | 102 | 28 | 37.84% | 101 | 1 |
| Dec 31, 2022 | 74 | 26 | 54.17% | 74 | 0 |
| Dec 31, 2021 | 48 | 22 | 84.62% | 48 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Recursion Pharmaceuticals | 600 |
| Galapagos NV | 558 |
| Ardelyx | 489 |
| Vericel | 398 |
| Nurix Therapeutics | 317 |
| Harmony Biosciences Holdings | 293 |
| Innoviva | 159 |
| Inhibrx Biosciences | 110 |
CAPR News
- 7 weeks ago - Capricor Therapeutics Stock Slides As Q4 Earnings Miss Estimates - Benzinga
- 7 weeks ago - Capricor Therapeutics Earnings Call Transcript: Q4 2025 - Transcripts
- 7 weeks ago - Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 weeks ago - Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy - GlobeNewsWire
- 7 weeks ago - Capricor Therapeutics Stock Jumps As FDA Resumes Deramiocel Review - Benzinga
- 7 weeks ago - Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA - GlobeNewsWire
- 7 weeks ago - What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday? - Benzinga
- 4 months ago - Capricor Therapeutics Transcript: Study Result - Transcripts